CXCR5 and nonpapillary renal cell carcinoma: Furthermore, the CXCL13/CXCR5 axis increases the expression of vimentin and N-cadherin, promotes EMT, and significantly enhances ccRCC EMT and proliferation in vivo through the AKT signaling pathway [32].